Allotment of 25,98,400 Equity Shares on Preferential basis
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 1.4 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hemant Surgical Industries has allotted 25,98,400 equity shares at Rs. 197 per share on a preferential basis, raising a total of Rs. 51.19 crores. Shares carry a face value of Rs. 10 with a premium of Rs. 187 each. All 12 allottees are non-promoters, with the largest allocations going to Singularity Large Value Fund I (5 lakh shares, ~Rs. 9.85 cr), Wealthwave Capital Fund (4 lakh shares, ~Rs. 7.88 cr), and individuals Swati Pokharna and Renudevi Hisaria (3 lakh shares each). The company's paid-up equity capital has expanded from Rs. 10.44 crore (1.04 crore shares) to Rs. 13.04 crore (1.30 crore shares), roughly a 25% increase in share count. The board approved the allotment on September 18, 2025 after receiving shareholder approval on August 30, 2025 and BSE in-principle approval on September 11, 2025.
The ~25% expansion in share count is a meaningful dilution for existing shareholders and may weigh on the stock price in the near term. On the positive side, Rs. 51 crore raised from a mix of institutional funds and well-known HNI investors signals confidence from sophisticated market participants. Investors should look out for the company's next announcement on how this capital will be deployed.